HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome
作者： A. Andriulli , F. Morisco , A. M. Ippolito , V. Di Marco , M. R. Valvano
DOI: 10.1007/S12072-014-9556-2
关键词: Hcv genotype 1 、 Alpha interferon 、 Hepacivirus 、 Hepatitis C 、 Sex factors 、 Ribavirin 、 Internal medicine 、 Medicine 、 Genotype 、 Hepatology 、 Bioinformatics 、 Virology
摘要: Aim To evaluate similarities and differences in HCV-1 subtypes 1a 1b the presenting clinical features response to peg-interferon ribavirin (Peg/RIBA).
springer.com
elsevier.com
sci-hub.se 参考文章(30)
M. SIMIN, J. BROK, D. STIMAC, C. GLUUD, L. L. GLUUD, Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C. Alimentary Pharmacology & Therapeutics. ,vol. 25, pp. 1153- 1162 ,(2007) , 10.1111/J.1365-2036.2007.03294.X
Ira M. Jacobson, John G. McHutchison, Geoffrey Dusheiko, Adrian M. Di Bisceglie, K. Rajender Reddy, Natalie H. Bzowej, Patrick Marcellin, Andrew J. Muir, Peter Ferenci, Robert Flisiak, Jacob George, Mario Rizzetto, Daniel Shouval, Ricard Sola, Ruben A. Terg, Eric M. Yoshida, Nathalie Adda, Leif Bengtsson, Abdul J. Sankoh, Tara L. Kieffer, Shelley George, Robert S. Kauffman, Stefan Zeuzem, Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection The New England Journal of Medicine. ,vol. 364, pp. 2405- 2416 ,(2011) , 10.1056/NEJMOA1012912
Julian P. T. Higgins, Simon G. Thompson, Quantifying heterogeneity in a meta‐analysis Statistics in Medicine. ,vol. 21, pp. 1539- 1558 ,(2002) , 10.1002/SIM.1186
Michael P Manns, John G McHutchison, Stuart C Gordon, Vinod K Rustgi, Mitchell Shiffman, Robert Reindollar, Zachary D Goodman, Kenneth Koury, Mei-Hsiu Ling, Janice K Albrecht, None, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. The Lancet. ,vol. 358, pp. 958- 965 ,(2001) , 10.1016/S0140-6736(01)06102-5
Matthew F. McCown, Sonal Rajyaguru, Simran Kular, Nick Cammack, Isabel Nájera, GT-1a or GT-1b subtype-specific resistance profiles for hepatitis C virus inhibitors telaprevir and HCV-796. Antimicrobial Agents and Chemotherapy. ,vol. 53, pp. 2129- 2132 ,(2009) , 10.1128/AAC.01598-08
Ingrid Imhof, Peter Simmonds, Genotype differences in susceptibility and resistance development of hepatitis C virus to protease inhibitors telaprevir (VX‐950) and danoprevir (ITMN‐191) Hepatology. ,vol. 53, pp. 1090- 1099 ,(2011) , 10.1002/HEP.24172
Nizar N. Zein, Clinical Significance of Hepatitis C Virus Genotypes Clinical Microbiology Reviews. ,vol. 13, pp. 223- 235 ,(2000) , 10.1128/CMR.13.2.223-235.2000
F. Nicot, L. Alric, K. Barange, S. Métivier, J.M. Dramard, J.M. Combis, B. Castan, J.J. Meurisse, J.L. Payen, D. Garipuy, H. Desmorat, J.M. Peron, S. Thebault, T. Morin, C. Renou, P. Barel, B. Guerin, Y. Imbert, S. Sire, K. Sauné, E. Chatelut, J. Izopet, Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy. Journal of Medical Virology. ,vol. 83, pp. 437- 444 ,(2011) , 10.1002/JMV.21976
Fred Poordad, Jonathan McCone Jr, Bruce R Bacon, Savino Bruno, Michael P Manns, Mark S Sulkowski, Ira M Jacobson, K Rajender Reddy, Zachary D Goodman, Navdeep Boparai, Mark J DiNubile, Vilma Sniukiene, Clifford A Brass, Janice K Albrecht, Jean-Pierre Bronowicki, None, Boceprevir for Untreated Chronic HCV Genotype 1 Infection The New England Journal of Medicine. ,vol. 364, pp. 1195- 1206 ,(2011) , 10.1056/NEJMOA1010494
Carla Kuiken, Peter Simmonds, Nomenclature and numbering of the hepatitis C virus. Methods of Molecular Biology. ,vol. 510, pp. 33- 53 ,(2009) , 10.1007/978-1-59745-394-3_4